Professional Education Professional Education
Medical Products and Solutions
Discover detailed information about medical products and solutions from Olympus.

Cytology Literature

Alsharif, M., et al. “Endobronchial ultrasound-guided transbronchial fine-needle aspiration: the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties.”
Am.J.Clin.Pathol. 130.3 (2008): 434-43.

 

Bardales, R. H., et al. “Review of endoscopic ultrasound-guided fine-needle aspiration cytology.”
Diagn. Cytopathol. 34.2 (2006): 140-75.

 

Billah, S., et al. “EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens.”
Cancer Cytopathol. 119.2 (2011): 111-17.

 

Cameron, S. E., R. S. Andrade, and S. E. Pambuccian. “Endobronchial ultrasound-guided transbronchial needle aspiration cytology: a state of the art review.”
Cytopathology 21.1 (2010): 6-26.

 

Kargi, A., D. Gurel, and B. Tuna. “The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.” Appl.Immunohistochem.Mol.Morphol. 15.4 (2007): 415-20.

 

Khayyata, S., et al. “Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.” Diagn.Cytopathol. 37.3 (2009): 178-83.

 

Kim, D. H. and M. S. Kwon. “Role of fine needle aspiration cytology, cell block preparation and CD63, P63 and CD56 immunostaining in classifying the specific tumor type of the lung.”
Acta Cytol. 54.1 (2010): 55-59.

 

Kopelman, Y., et al. “Value of EUS-FNA cytological preparations compared with cell block sections in the diagnosis of pancreatic solid tumours.” Cytopathology 22.3 (2011): 174-78.

 

Lau, S. K., D. J. Luthringer, and R. N. Eisen. “Thyroid transcription factor-1: a review.”
Appl.Immunohistochem.Mol.Morphol. 10.2 (2002): 97-102.

 

LeBlanc, J. K., et al. “A prospective study comparing rapid assessment of smears and ThinPrep for endoscopic
ultrasound-guided fine-needle aspirates.” Endoscopy 42.5 (2010): 389-94.

 

Loo, P. S., et al. “Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.”
J.Thorac.Oncol. 5.4 (2010): 442-47.

 

Maemondo, M., et al. “Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.”
N.Engl.J.Med. 362.25 (2010): 2380-88.

 

Mayall, F. G., et al. “The gross appearances of fine needle aspiration cytology samples.”
J.Clin.Pathol. 62.1 (2009): 57-59.

 

Micames, C. G., et al. “Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging:
A systematic review and metaanalysis.” Chest 131.2 (2007): 539-48.

 

Mitsudomi, T., et al. “Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.”
Lancet Oncol. 11.2 (2010): 121-28.

 

Mok, T. S., et al. “Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.”
N.Engl.J.Med. 361.10 (2009): 947-57.

 

Monaco, S. E., M. J. Schuchert, and W. E. Khalbuss. “Diagnostic difficulties and pitfalls in rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration.” Cytojournal. 7 (2010): 9.

 

Motosugi, U., et al. “Radiology contributes to better cytological diagnosis of lung tumors.”
Lung Cancer 66.1 (2009): 80-84.

 

Nakajima, T., et al. “Assessment of epidermal growth factor receptor mutation by endobronchial ultrasoundguided transbronchial needle aspiration.” Chest 132.2 (2007): 597-602.

 

Nguyen, L. T., et al. “Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population.” Clin.Microbiol.Infect. 16.8 (2010): 1264-69.

 

Nguyen, Y. P., et al. “Reliability of gross visual assessment of specimen adequacy during EUS-guided FNA of pancreatic masses.” Gastrointest.Endosc. 69.7 (2009): 1264-70.

 

Nicholson, A. G., et al. “Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.” J.Thorac.Oncol. 5.4 (2010): 436-41.

 

Noda, Y., et al. “Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples obtained by endoscopic ultrasound-guided fine-needle aspiration.”
J.Gastroenterol. 45.8 (2010): 868-75.

 

Rekhtman, N., et al. “Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.”
J.Thorac.Oncol. 6.3 (2011): 451-58.

 

Rivera, M. P. and A. C. Mehta. “Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).” Chest 132.3 Suppl (2007): 131S-48S.

 

Rossi, G., et al. “A reevaluation of the clinical significance of histological subtyping of non–small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.” Int.J.Surg.Pathol. 17.3 (2009): 206-18.

 

Sakairi, Y., et al. “EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.” Clin.Cancer Res. 16.20 (2010): 4938-45.

 

Savoy, A. D., et al. “Can endosonographers evaluate on-site cytologic adequacy? A comparison with cytotechnologists.” Gastrointest.Endosc. 65.7 (2007): 953-57.

 

Scagliotti, G. V., et al. “Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.”
J.Clin.Oncol. 26.21 (2008): 3543-51.

 

Skov, B. G., et al. “Cytopathologic diagnoses of fine-needle aspirations from endoscopic ultrasound of the mediastinum: reproducibility of the diagnoses and representativeness of aspirates from lymph nodes.”
Cancer 111.4 (2007): 234-41.

 

Skov, B. G., et al. “A technique to improve diagnostic information from fine-needle aspirations: immunohistochemistry on cytoscrape.” Cancer 117.2 (2009): 120-27.

 

Smouse, J. H., et al. “EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.” Cancer 117.1 (2009): 67-72.

 

Stoll, L. M., et al. “Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration.” Cancer Cytopathol. 118.5 (2010): 278-86.

 

Sun, W., et al. “The diagnostic value of endobronchial ultrasound-guided needle biopsy in lung cancer and mediastinal adenopathy.” Diagn.Cytopathol. 38.5 (2010): 337-42.

 

Travis, W. D., et al. “International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.”
J.Thorac.Oncol. 6.2 (2011): 244-85.

 

Travis, W. D., et al. “Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.” J.Thorac.Oncol. 5.4 (2010): 411-14.

 

Varela-Lema, L., A. Fernandez-Villar, and A. Ruano-Ravina. “Effectiveness and safety of endobronchial ultrasound- transbronchial needle aspiration: a systematic review.” Eur.Respir.J. 33.5 (2009): 1156-64.

 

Wallace, W. A. and D. M. Rassl. “Accuracy of Cell Typing in Non-Small Cell Lung Cancer by EBUS.”
Eur.Respir.J. (2011).